Literature DB >> 32631945

Clostridioides difficile para-Cresol Production Is Induced by the Precursor para-Hydroxyphenylacetate.

Mark A Harrison1, Alexandra Faulds-Pain1, Harparkash Kaur1, Bruno Dupuy2, Adriano O Henriques3, Isabelle Martin-Verstraete2,4, Brendan W Wren1, Lisa F Dawson5.   

Abstract

Clostridioides difficile is an etiological agent for antibiotic-associated diarrheal disease. C. difficile produces a phenolic compound, para-cresol, which selectively targets gammaproteobacteria in the gut, facilitating dysbiosis. C. difficile decarboxylates para-hydroxyphenylacetate (p-HPA) to produce p-cresol by the action of the HpdBCA decarboxylase encoded by the hpdBCA operon. Here, we investigate regulation of the hpdBCA operon and directly compare three independent reporter systems; SNAP-tag, glucuronidase gusA, and alkaline phosphatase phoZ reporters to detect basal and inducible expression. We show that expression of hpdBCA is upregulated in response to elevated p-HPA. In silico analysis identified three putative promoters upstream of hpdBCA operon-P1, P2, and Pσ54; only the P1 promoter was responsible for both basal and p-HPA-inducible expression of hpdBCA We demonstrated that turnover of tyrosine, a precursor for p-HPA, is insufficient to induce expression of the hpdBCA operon above basal levels because it is inefficiently converted to p-HPA in minimal media. We show that induction of the hpdBCA operon in response to p-HPA occurs in a dose-dependent manner. We also identified an inverted palindromic repeat (AAAAAG-N13-CTTTTT) upstream of the hpdBCA start codon (ATG) that is essential for inducing transcription of the hpdBCA operon in response to p-HPA, which drives the production of p-cresol. This provides insights into the regulatory control of p-cresol production, which affords a competitive advantage for C. difficile over other intestinal bacteria, promoting dysbiosis.IMPORTANCE Clostridioides difficile infection results from antibiotic-associated dysbiosis. para-Cresol, a phenolic compound produced by C. difficile, selectively targets gammaproteobacteria in the gut, facilitating dysbiosis. Here, we demonstrate that expression of the hpdBCA operon, encoding the HpdBCA decarboxylase which converts p-HPA to p-cresol, is upregulated in response to elevated exogenous p-HPA, with induction occurring between >0.1 and ≤0.25 mg/ml. We determined a single promoter and an inverted palindromic repeat responsible for basal and p-HPA-inducible hpdBCA expression. We identified turnover of tyrosine, a p-HPA precursor, does not induce hpdBCA expression above basal level, indicating that exogenous p-HPA was required for p-cresol production. Identifying regulatory controls of p-cresol production will provide novel therapeutic targets to prevent p-cresol production, reducing C. difficile's competitive advantage. © Crown copyright 2020.

Entities:  

Keywords:  Clostridioides difficilezzm321990; Clostridium difficilezzm321990; GusA; PhoZ; SNAP tag; para-cresol; reporter; transcription; transcriptional regulation; transcriptional reporter; tyrosine, p-HPA; σ54

Mesh:

Substances:

Year:  2020        PMID: 32631945      PMCID: PMC7925072          DOI: 10.1128/JB.00282-20

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  41 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile.

Authors:  Laure Saujet; Marc Monot; Bruno Dupuy; Olga Soutourina; Isabelle Martin-Verstraete
Journal:  J Bacteriol       Date:  2011-05-13       Impact factor: 3.490

Review 3.  Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence.

Authors:  Konstantinos Z Vardakas; Konstantinos A Polyzos; Konstantina Patouni; Petros I Rafailidis; George Samonis; Matthew E Falagas
Journal:  Int J Antimicrob Agents       Date:  2012-03-06       Impact factor: 5.283

4.  Use of mCherry Red fluorescent protein for studies of protein localization and gene expression in Clostridium difficile.

Authors:  Eric M Ransom; Craig D Ellermeier; David S Weiss
Journal:  Appl Environ Microbiol       Date:  2014-12-19       Impact factor: 4.792

5.  Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites.

Authors:  Haitham A Hussain; Adam P Roberts; Peter Mullany
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

6.  Clostridium difficile toxin B acts on the GTP-binding protein Rho.

Authors:  I Just; G Fritz; K Aktories; M Giry; M R Popoff; P Boquet; S Hegenbarth; C von Eichel-Streiber
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

7.  Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants.

Authors:  Lisa F Dawson; Esmeralda Valiente; Elizabeth H Donahue; George Birchenough; Brendan W Wren
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

8.  The CspC pseudoprotease regulates germination of Clostridioides difficile spores in response to multiple environmental signals.

Authors:  Amy E Rohlfing; Brian E Eckenroth; Emily R Forster; Yuzo Kevorkian; M Lauren Donnelly; Hector Benito de la Puebla; Sylvie Doublié; Aimee Shen
Journal:  PLoS Genet       Date:  2019-07-05       Impact factor: 5.917

9.  The spore differentiation pathway in the enteric pathogen Clostridium difficile.

Authors:  Fátima C Pereira; Laure Saujet; Ana R Tomé; Mónica Serrano; Marc Monot; Evelyne Couture-Tosi; Isabelle Martin-Verstraete; Bruno Dupuy; Adriano O Henriques
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

10.  Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.

Authors:  Kamal Desai; Swati B Gupta; Erik R Dubberke; Vimalanand S Prabhu; Chantelle Browne; T Christopher Mast
Journal:  BMC Infect Dis       Date:  2016-06-18       Impact factor: 3.090

View more
  2 in total

1.  Production of p-cresol by Decarboxylation of p-HPA by All Five Lineages of Clostridioides difficile Provides a Growth Advantage.

Authors:  Mark A Harrison; Harparkash Kaur; Brendan W Wren; Lisa F Dawson
Journal:  Front Cell Infect Microbiol       Date:  2021-10-29       Impact factor: 5.293

2.  Clostridioides difficile Infection Dysregulates Brain Dopamine Metabolism.

Authors:  Akhil A Vinithakumari; Piyush Padhi; Belen Hernandez; Susanne Je-Han Lin; Aaron Dunkerson-Kurzhumov; Lucas Showman; Matthew Breitzman; Caroline Stokes; Yousuf Sulaiman; Chandra Tangudu; Deepa A Kuttappan; Muhammed S Muyyarikkandy; Auriel A Willette; Gregory J Phillips; Vellareddy Anantharam; Ann Perera; Brett A Sponseller; Anumantha Kanthasamy; Shankumar Mooyottu
Journal:  Microbiol Spectr       Date:  2022-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.